Comparative study of serum BNP between chronic pulmonary heart disease and left heart failure

Jing-hua XIAO,Sheng-ming LIU,Dong-bo TIAN,Zhi-ping FU,Hai-e WANG,Xiang YANG
DOI: https://doi.org/10.3969/j.issn.1009-6663.2015.012.029
2015-01-01
Abstract:Objective To compare the difference of serum BNP at different stages of chronic pulmonary heart disease and left heart failure, and to explore the relationship of BNP to RV, RVOT and LVEF. Methods There were four groups in the study, the control group ( group A) , the COPD combined with chronic pulmonary heart disease at compensatory stage ( group B) , the COPD combined with chronic pulmonary heart disease at decompensa-tory stage ( group C) , and the left heart failure group ( D) , 100 cases in each group. Their BNP, pulmonary function test and heart doppler ultrasound were tested. The difference of serum BNP levels among the above groups was com-pared. Correlation analysis was used to identify significant relationships between BNP and variables of interest. Re-sults The serum level of BNP in the group C was much higher than that in the group B ( P<0. 001 ) . And it was higher in the group D than in the group C. In patients with chronic pulmonary heart disease, there was a positive cor-relation of BNP with RV, RVOT and PASP, a negative correlation with FEV1%, and no correlation with LVEF%. The best cut-off value of BNP on diagnosis in the group B and C was 318. 7 pg/ml, and it was 784. 8 pg/ml in the group C and D. Conclusion The serum level of BNP is related with the clinical stage of chronic pulmonary heart disease. Ambulatory monitoring on serum BNP level is important and significant to make a diagnosis.
What problem does this paper attempt to address?